While incorporated in bone matrix, alendronate is not pharmacologically active.
From the online.wsj.com
Alendronate decreases bone resorption without directly inhibiting bone formation.
From the online.wsj.com
The effects of parathyroid hormone, alendronate, or both in men with osteoporosis.
From the nature.com
An analysis of the safety data from FIT showed that alendronate is well tolerated.
From the sciencedaily.com
Intravenous ranitidine was shown to double the bioavailability of oral alendronate.
From the online.wsj.com
The initial placebo group was, in turn, switched to a regimen of alendronate.
From the washingtonpost.com
Lane N. Long-term effects of treatment with alendronate for patients with osteoporosis.
From the nature.com
The medications include alendronate, the generic version of osteoporosis medication Fosamax.
From the thenewstribune.com
Daily and cyclic parathyroid hormone in women receiving alendronate.
From the nature.com
More examples
A tablet (trade name Fosamax) prescribed to prevent or treat osteoporosis in women after menopause
Alendronic acid (INN) or alendronate sodium (USAN, sold as Fosamax by Merck) is a bisphosphonate drug used for osteoporosis and several other bone diseases. It is marketed alone as well as in combination with vitamin D (2,800 U and 5600 U, under the name Fosamax+D). Merck's U.S. ...
Any salt or ester of alendronic acid; The sodium salt of alendronic acid used to treat osteoporosis
A drug in the bisphosphonate family that is prescribed under the name Fosamax. It is given as a daily or weekly tablet. It is approved by the US FDA to treat osteoporosis. It currently is in clinical trials as a treatment for OI in older children and adults. ...
Medication used to treat osteoporosis. Part of the class of drugs called bisphosphonates. Sold under brand name Fosamax and also available as a generic.
A powerful form of bisphosphonate treatment for osteoporosis that prevents spine and hip fracture. It is expensive and may have serious negative effects on the esophagus and stomach. It may be taken once a week.
Most commonly prescribed bisphosphonate in the UK. Works by disrupting osteoclast formation and function.
A bisphosphonate approved by the US Food and Drug Administration for prevention and treatment of osteoporosis; accumulates and persists in the bone. Studies indicate about a 50 percent reduction in vertebral and hip fractures in patients with osteoporosis.